24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Clinical Trials
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:36
The AI revolution is already here - and this time, it’s not waiting for anyone
12:49
Navan hits lowest market cap since IPO as shares slide 50% in less than two months
12:17
CTech’s Book Review: Satya Nadella’s reflection on Microsoft’s transformation
12:16
How CatAmmon is tackling hydrogen’s stalled adoption
More stories
Buzz
Most popular
Daily
Weekly
1
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
2
“Younger people are getting cancer more and more. We have to make kinder medicines.”
3
The $2.3 billion mystery arms deal Israel won’t explain
4
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
5
Navan shares extend decline as losses widen and CFO plans exit
More news
Clinical Trials
4 stories about Clinical Trials
ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit
04.04.18
|
Asaf Shalev
After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators
Company that Develops Injectable Bone Grafts Expands Clinical Trial
12.03.18
|
Dror Reich
Unlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure
Bonus Biogroup Says First Lab-Grown Leg Bone Transplanted in Patient
21.12.17
|
Lilach Baumer
The Israel-based company's injectable bone grafts are made from fat cells taken from the patients to negate the risk of tissue rejection
Automated Medical Diagnosis Startup Raises $30 Million
19.09.17
|
Omer Kabir
Israel-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense